Genetics of acquired long QT syndrome

被引:169
作者
Roden, DM
Viswanathan, PC
机构
[1] Vanderbilt Univ, Oates Inst Expt Therapeut, Sch Med, Dept Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Anesthesiol, Sch Med, Nashville, TN 37232 USA
关键词
D O I
10.1172/JCI25539
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The QT interval is the electrocardiographic manifestation of ventricular repolarization, is variable under physiologic conditions, and is measurably prolonged by many drugs. Rarely, however, individuals with normal baseline intervals may display exaggerated QT interval prolongation, and the potentially fatal polymorphic ventricular tachycardia torsade de pointes, with drugs or other environmental stressors such as heart block or heart failure. This review summarizes the molecular and cellular mechanisms underlying this acquired or drug-induced form of long QT syndrome, describes approaches to the analysis of a role for DNA variants in the mediation of individual susceptibility, and proposes that these concepts may be generalizable to common acquired arrhythmias.
引用
收藏
页码:2025 / 2032
页数:8
相关论文
共 95 条
[1]   MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia [J].
Abbott, GW ;
Sesti, F ;
Splawski, I ;
Buck, ME ;
Lehmann, WH ;
Timothy, KW ;
Keating, MT ;
Goldstein, SAN .
CELL, 1999, 97 (02) :175-187
[2]   Ethnic differences in cardiac potassium channel variants: Implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome [J].
Ackerman, MJ ;
Tester, DJ ;
Jones, GS ;
Will, ML ;
Burrow, CR ;
Curran, ME .
MAYO CLINIC PROCEEDINGS, 2003, 78 (12) :1479-1487
[3]   Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure [J].
Akar, FG ;
Rosenbaum, DS .
CIRCULATION RESEARCH, 2003, 93 (07) :638-645
[4]   Unique topographical distribution of m cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome [J].
Akar, FG ;
Yan, GX ;
Antzelevitch, C ;
Rosenbaum, DS .
CIRCULATION, 2002, 105 (10) :1247-1253
[5]   Cardiac repolarization: Current knowledge, critical gaps, and new approaches to drug development and patient management [J].
Anderson, ME ;
Al-Khatib, SM ;
Roden, DM ;
Califf, RM .
AMERICAN HEART JOURNAL, 2002, 144 (05) :769-781
[6]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[7]  
[Anonymous], ACM T ASIAN LANGUAGE
[8]   Arrhythmogenic mechanisms of QT prolonging drugs: Is QT prolongation really the problem? [J].
Antzelevitch, C .
JOURNAL OF ELECTROCARDIOLOGY, 2004, 37 :15-24
[9]   Brugada syndrome - Report of the second consensus conference - Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association [J].
Antzelevitch, C ;
Brugada, P ;
Borggrefe, M ;
Brugada, J ;
Brugada, R ;
Corrado, D ;
Gussak, I ;
LeMarec, H ;
Nademanee, K ;
Riera, ARP ;
Shimizu, W ;
Schulze-Bahr, E ;
Tan, H ;
Wilde, A .
CIRCULATION, 2005, 111 (05) :659-670
[10]   Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties [J].
Antzelevitch, C ;
Belardinelli, L ;
Zygmunt, AC ;
Burashnikov, A ;
Di Diego, JM ;
Fish, JM ;
Cordeiro, JM ;
Thomas, G .
CIRCULATION, 2004, 110 (08) :904-910